-
Advancing Transformational Innovation in HIV Research: A Pillar of Gilead’s Efforts to Help End the Global HIV EpidemicSponsored Learn about Gilead’s innovative approach to continuous scientific discovery as part of the company’s leadership and commitment that aims to help end the HIV epidemic for everyone, everywhere.
SPONSORED -
66-year-old likely cured of HIV after stem cell transplantA patient entered remission from cancer and HIV after a transplant.
-
A third person has been cured of HIV, scientists reportShe received stem cells from umbilical cord blood.
-
Newfound variant of HIV progresses to AIDS faster and may be more transmissibleStandard treatments work equally well against the variant.
-
1st long-acting injection to prevent HIV has been approved by the FDAThe new drug, Apretude, is an alternative to daily pills for HIV prevention.
-
Patient's immune system 'naturally' cures HIV in the second case of its kind
Two patients' immune systems have now naturally rid themselves of the infection.
-
HIV vaccine stimulates 'rare immune cells' in early human trialsA new vaccine approach to HIV that stimulates a set of rare immune cells showed 97% success at targeting those cells in its first tests in humans.
-
Scientists zoom in on HIV inside a test tube, find critical steps in infectionThe experiments highlight the role of the virus's cone-shaped shell in infection.
-
Study hints at how 'elite controllers' stifle HIVSome people can suppress HIV without antiviral drugs — how?
